Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 393 |
---|---|
Genomic Coordinate (GRCh38) | g.22133523_22133624dup |
Variant | c.1303-?_1404+?dup |
Variant Start Position | 1303 |
Location | Intron 11 |
Amino Acid Change | Gain (Exon 12) |
ACMG Call | Pathogenic |
ACMG Call Last Revised Date | 2022-02-02 00:00:00 |
Predicted ACMG Call | - | Effect Type | Duplication |
Variant Type | CNV |
PMID | 34806794 |
Article Count | 1 |
Times Observed | 3-5 |
Clinical Phenotype | Lower limb deformities, Reduced Serum Phosphate |
ACMG Categories | - |
ACMG Explanations | - |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | - |
No Contrary Evidence Found | No |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | - |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |